Loading…
Revenue and net loss figures released for the period.
Harvard Bioscience, Inc. announced on 2025-05-12 Harvard Bioscience announced its first quarter 2025 financial results.
The announcement cited $21.8 million, $24.5 million, 56.0%, 60.3%, -$50.3 million, -$48.0 million, -$4.7 million, -$1.3 million, $0.8 million, $1.6 million, $3.0 million, $1.4 million, $18 million, $20 million, 55%, and 57%.
Harvard Bioscience Inc has a free float of 34,298,300 shares and 44,579,700 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.